Literature DB >> 25822939

Tight junction protein claudin-6 inhibits growth and induces the apoptosis of cervical carcinoma cells in vitro and in vivo.

Xiaowei Zhang1, Yang Ruan, Yanru Li, Dongjing Lin, Chengshi Quan.   

Abstract

Claudin-6, a member of claudin family integral membrane proteins, has recently been reported to be a tumor suppressor for breast cancer. However, whether it plays a role in other types of cancer remains unclear. In the present study, we showed that the expression of claudin-6 is down-regulated in cervical carcinoma tissues as revealed by immunohistochemistry. Through over-expressing claudin-6 in HeLa and C33A cervical carcinoma cells, we found that claudin-6 is localized at plasma membrane and it increases transepithelial electrical resistance of the cells. Gain of claudin-6 expression suppresses cell proliferation, colony formation in vitro, and tumor growth in vivo. The effects are accompanied and potentially caused by promotion of tumor cell apoptosis. Taken together, these results suggest that claudin-6 may function as a tumor suppressor and loss of claudin-6 contributes to enhanced tumorigenic properties of cervical carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25822939     DOI: 10.1007/s12032-015-0600-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  35 in total

Review 1.  Tight junction proteins.

Authors:  L González-Mariscal; A Betanzos; P Nava; B E Jaramillo
Journal:  Prog Biophys Mol Biol       Date:  2003-01       Impact factor: 3.667

Review 2.  Dynamics and functions of tight junctions.

Authors:  Emily Steed; Maria S Balda; Karl Matter
Journal:  Trends Cell Biol       Date:  2010-01-12       Impact factor: 20.808

3.  Claudin-6 is a nonspecific marker for malignant rhabdoid and other pediatric tumors.

Authors:  Lisa M Sullivan; Theresa Yankovich; Paul Le; Daniel Martinez; Mariarita Santi; Jaclyn A Biegel; Bruce R Pawel; Alexander R Judkins
Journal:  Am J Surg Pathol       Date:  2012-01       Impact factor: 6.394

4.  Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Authors:  Scott L Kominsky; Pedram Argani; Dorian Korz; Ella Evron; Venu Raman; Elizabeth Garrett; Alan Rein; Guido Sauter; Olli-P Kallioniemi; Saraswati Sukumar
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

5.  Tight junction protein, claudin-6, downregulates the malignant phenotype of breast carcinoma.

Authors:  Qiong Wu; Yafang Liu; Yue Ren; Xiaoming Xu; Lina Yu; Yulin Li; Chengshi Quan
Journal:  Eur J Cancer Prev       Date:  2010-05       Impact factor: 2.497

Review 6.  Tumour-cell invasion and migration: diversity and escape mechanisms.

Authors:  Peter Friedl; Katarina Wolf
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

7.  Identification of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays.

Authors:  Chengshi Quan; Shi-Jiang Lu
Journal:  Carcinogenesis       Date:  2003-08-01       Impact factor: 4.944

8.  Analysis of cell cycle by flow cytometry.

Authors:  Piotr Pozarowski; Zbigniew Darzynkiewicz
Journal:  Methods Mol Biol       Date:  2004

9.  Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells.

Authors:  Makoto Osanai; Masaki Murata; Hideki Chiba; Takashi Kojima; Norimasa Sawada
Journal:  Cancer Sci       Date:  2007-07-23       Impact factor: 6.716

10.  The distinct expression patterns of claudin-2, -6, and -11 between human gastric neoplasms and adjacent non-neoplastic tissues.

Authors:  Zhe Lin; Xiaowei Zhang; Zhijing Liu; Qihui Liu; Liping Wang; Yan Lu; Yuanyuan Liu; Min Wang; Minlan Yang; Xiangshu Jin; Chengshi Quan
Journal:  Diagn Pathol       Date:  2013-08-06       Impact factor: 2.644

View more
  14 in total

1.  C-terminal of E1A binding protein 2 promotes the malignancy of osteosarcoma cells via JAK1/Stat3 signaling.

Authors:  Pengyun Wang; Benfeng Yu; Chengyan Wang; Shu Zhou
Journal:  J Cell Commun Signal       Date:  2019-06-19       Impact factor: 5.782

2.  The expression and the tumor suppressor role of CLDN6 in colon cancer.

Authors:  Huinan Qu; Min Wang; Miaomiao Wang; Yuanyuan Liu; Chengshi Quan
Journal:  Mol Cell Biochem       Date:  2022-06-14       Impact factor: 3.396

Review 3.  Candidate biomarkers in the cervical vaginal fluid for the (self-)diagnosis of cervical precancer.

Authors:  Xaveer Van Ostade; Martin Dom; Wiebren Tjalma; Geert Van Raemdonck
Journal:  Arch Gynecol Obstet       Date:  2017-11-15       Impact factor: 2.344

4.  Differences in the expression profiles of claudin proteins in human nasopharyngeal carcinoma compared with non-neoplastic mucosa.

Authors:  Xiaowei Zhang; Haiming Wang; Qian Li; Yunpeng Liu; Peiqing Zhao; Tao Li
Journal:  Diagn Pathol       Date:  2018-02-05       Impact factor: 2.644

5.  Bioinformatic analysis reveals potential properties of human Claudin-6 regulation and functions.

Authors:  Dongjing Lin; Yaxiong Guo; Yanru Li; Yang Ruan; Mingzi Zhang; Xiangshu Jin; Minlan Yang; Yan Lu; Peiye Song; Shuai Zhao; Bing Dong; Yinping Xie; Qihua Dang; Chengshi Quan
Journal:  Oncol Rep       Date:  2017-06-27       Impact factor: 3.906

6.  Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma.

Authors:  Lemeng Sun; Liangshu Feng; Jiuwei Cui
Journal:  Diagn Pathol       Date:  2018-09-15       Impact factor: 2.644

7.  C-terminal of E1A binding protein 1 enhances the migration of gastric epithelial cells and has a clinicopathologic significance in human gastric carcinoma.

Authors:  Can Wang; Min Wang; Bocheng Xing; Zhaocheng Chi; Hongyu Wang; Chunxiao Lie; Han Dong
Journal:  Onco Targets Ther       Date:  2019-07-02       Impact factor: 4.147

8.  Pre-mRNA Processing Factor 8 Accelerates the Progression of Hepatocellular Carcinoma by Regulating the PI3K/Akt Pathway.

Authors:  Shouhan Wang; Min Wang; Bin Wang; Jiaqi Chen; Xianbin Cheng; Xiaodan Sun
Journal:  Onco Targets Ther       Date:  2020-05-26       Impact factor: 4.147

9.  Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.

Authors:  Siyao Zuo; Xin Li; Wanguo Bao; Shanshan Li
Journal:  Sci Rep       Date:  2020-06-01       Impact factor: 4.379

10.  CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin/ERK signaling pathway.

Authors:  Xiaowei Zhang; Haiming Wang; Qian Li; Tao Li
Journal:  Cancer Cell Int       Date:  2018-10-17       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.